Who owns Glycomimetics?
- Ticker: GLYC
- CUSIP Number: 38000q102
Tip: Access positions for across all investors
Analyze quarterly positions in Glycomimetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Glycomimetics stock
Who bought or sold Glycomimetics this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 9.5M | $23M | 0% | Dec 2023 |
|
Artal Group | 8.6M | $20M | 0% | Dec 2023 |
|
NEA Management Company | 4.8M | $11M | 0% | Dec 2023 |
|
Octagon Capital Advisors | 3.0M | $7.1M | 0% | Dec 2023 |
|
Vanguard Group | 2.4M | $5.7M | 0% | Dec 2023 |
|
Axa | 1.6M | $2.4M | 0% | Sep 2023 |
|
Goldman Sachs Group | 919k | $2.2M | 16% | Dec 2023 |
|
Acadian Asset Management | 844k | $1.3M | -27% | Sep 2023 |
|
BlackRock | 735k | $1.1M | -6% | Sep 2023 |
|
Geode Capital Management | 460k | $690k | -3% | Sep 2023 |
|
Susquehanna International | 252k | $378k | 34% | Sep 2023 |
|
Renaissance Technologies | 201k | $302k | 73% | Sep 2023 |
|
GSA Capital Partners | 201k | $474k | 114% | Dec 2023 |
|
State Street Corporation | 187k | $280k | 0% | Sep 2023 |
|
Bridgeway Capital Management | 172k | $258k | 27% | Sep 2023 |
|
Two Sigma Advisers | 165k | $390k | -24% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 143k | $338k | -4% | Dec 2023 |
|
Northern Trust | 106k | $159k | -12% | Sep 2023 |
|
Mjp Associates | 101k | $238k | 100% | Dec 2023 |
|
Advisor OS | 101k | $238k | 100% | Dec 2023 |
|
Franklin Resources | 96k | $226k | 0% | Dec 2023 |
|
Simplex Trading | 72k | $170k | 100% | Dec 2023 |
|
Two Sigma Investments | 60k | $141k | -48% | Dec 2023 |
|
Sargent Investment Group | 58k | $137k | 0% | Dec 2023 |
|
Jane Street | 57k | $135k | 186% | Dec 2023 |
|
Intellectus Partners | 51k | $120k | -18% | Dec 2023 |
|
Letko, Brosseau & Associates | 45k | $107k | 0% | Dec 2023 |
|
Morgan Stanley | 40k | $61k | -59% | Sep 2023 |
|
Millennium Management | 39k | $92k | -39% | Dec 2023 |
|
Ieq Capital | 38k | $91k | 0% | Dec 2023 |
|
Virtu Financial | 34k | $81k | 100% | Dec 2023 |
|
XTX Topco | 33k | $49k | 9% | Sep 2023 |
|
Group One Trading | 28k | $43k | -48% | Sep 2023 |
|
Longwood Capital Partners | 28k | $41k | 100% | Sep 2023 |
|
Bank of New York Mellon | 25k | $58k | -1% | Dec 2023 |
|
Citadel Advisors | 24k | $58k | 100% | Dec 2023 |
|
Charles Schwab Investment Management | 22k | $53k | 0% | Dec 2023 |
|
Citigroup | 22k | $51k | 100% | Dec 2023 |
|
Bank of America Corporation | 20k | $47k | 143% | Dec 2023 |
|
683 Capital Management | 19k | $46k | 100% | Dec 2023 |
|
Tobias Financial Advisors | 15k | $23k | 0% | Sep 2023 |
|
LPL Financial | 13k | $20k | 30% | Sep 2023 |
|
Marshall Wace | 13k | $30k | 100% | Dec 2023 |
|
Pine Valley Investments Ltd Liability | 13k | $30k | 0% | Dec 2023 |
|
Tower Research Capital | 4.7k | $7.0k | -46% | Sep 2023 |
|
Hartford Financial Management | 3.5k | $8.3k | 0% | Dec 2023 |
|
Truvestments Capital | 2.1k | $3.1k | 0% | Sep 2023 |
|
Jpmorgan Chase & Co | 1.6k | $3.8k | 246% | Dec 2023 |
|
Rhumbline Advisers | 1.0k | $2.5k | 0% | Dec 2023 |
|
UBS Group | 683.00 | $1.6k | 100% | Dec 2023 |
|
ORG Partners | 500.00 | $1.2k | 100% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 481.00 | $1.1k | 0% | Dec 2023 |
|
Qube Research & Technologies | 399.00 | $599.018700 | 100% | Sep 2023 |
|
Wells Fargo & Company | 377.00 | $889.983900 | 6% | Dec 2023 |
|
Barclays | 76.00 | $0 | -50% | Dec 2023 |
|
Who sold out of Glycomimetics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Dimensional Fund Advisors | Sep 2023 | 45k | $67k |
Chicago Partners Investment | Sep 2023 | 20k | $23k |
Commonwealth Equity Services | Sep 2023 | 10k | $15k |
Creative Planning | Sep 2023 | 10k | $15k |
Carolinas Wealth Consulting | Jun 2023 | 395.00 | $686.984000 |
Signature | Sep 2023 | 100.00 | $150.000000 |